Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Cardiovascular/Renal Drugs Advisory Committee meets this month

Oct. 14, 1997

DCLHb evaluated in critically ill patients

Oct. 13, 1997

CV Therapeutics moves ranolazine to phase III

Oct. 13, 1997

Renal effects of NO donor FK-409 in dogs

Oct. 10, 1997

BMS and ICAgen establish ion channel collaboration

Oct. 10, 1997

Hoechst discloses antiischemic agents

Oct. 10, 1997

Spotlight on angiotensin II blocker/ACE inhibitor combination therapy

Oct. 10, 1997

Mutual recognition approval obtained for Astra's angiotensin II blocker

Oct. 9, 1997

Flocor pivotal trial supported by FDA grant

Oct. 9, 1997

Mylan receives FDA approval for generic verapamil

Oct. 9, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 13, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
First cruise ship hantavirus genome points to zoonotic spillover
BioWorld
The initial appraisal of the first complete genome sequence of a hantavirus isolated from a patient in Switzerland who was a passenger on the cruise ship MV...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...